Welcome to our dedicated page for Parametric Equity Plus ETF news (Ticker: PEPS), a resource for investors and traders seeking the latest updates and insights on Parametric Equity Plus ETF stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Parametric Equity Plus ETF's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Parametric Equity Plus ETF's position in the market.
Morgan Stanley Investment Management (MSIM) has launched the Parametric Equity Plus ETF (PEPS), expanding its ETF platform to $3.3 billion in assets across 16 strategies. The new US large-cap equity ETF, listed on Nasdaq, combines direct indexing capabilities with options and risk management strategies. This launch marks Parametric's third ETF and follows the recent conversion of three active fixed income mutual funds to Eaton Vance ETFs. The platform now includes three Parametric-branded, six Calvert-branded, and seven Eaton Vance-branded strategies.
FAQ
What is the current stock price of Parametric Equity Plus ETF (PEPS)?
